PATRICIA J EIFEL

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Oncology
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One. 2021; 16(3):e0247905. PMID: 33662003.
      Citations: 2     Fields:    Translation:HumansCells
    2. Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):413-424. PMID: 32905846.
      Citations: 3     Fields:    Translation:Humans
    3. Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer. 2020 06 01; 126(11):2607-2613. PMID: 32125711.
      Citations: 1     Fields:    Translation:Humans
    4. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):163-171. PMID: 31987960.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    5. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 11 01; 17(11):1374-1391. PMID: 31693991.
      Citations: 9     Fields:    Translation:Humans
    6. Eifel PJ. High intermediate risk endometrial cancer. What is it? Int J Gynecol Cancer. 2019 09; 29(7):1084-1085. PMID: 31474586.
      Citations: 1     Fields:    Translation:Humans
    7. Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol. 2019 07; 154(1):22-28. PMID: 31109659.
      Citations: 4     Fields:    Translation:Humans
    8. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 01; 17(1):64-84. PMID: 30659131.
      Citations: 140     Fields:    Translation:HumansCellsPHPublic Health
    9. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Feb; 16(2):170-199. PMID: 29439178.
      Citations: 110     Fields:    Translation:Humans
    10. Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018 03; 148(3):474-479. PMID: 29336837.
      Citations: 1     Fields:    Translation:Humans
    11. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. 2018 01; 28(1):114-121. PMID: 28930812.
      Citations: 1     Fields:    Translation:Humans
    12. Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138. PMID: 29089122.
      Citations: 12     Fields:    Translation:Humans
    13. Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol. 2017 07; 146(1):87-93. PMID: 28506563.
      Citations: 3     Fields:    Translation:Humans
    14. Swanick CW, Eifel PJ, Klopp AH. In Reply to Mazeron et al. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):639. PMID: 28126311.
      Citations:    Fields:    
    15. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 01; 15(1):92-120. PMID: 28040721.
      Citations: 35     Fields:    Translation:Humans
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28109633.
      Citations: 1     Fields:    Translation:Humans
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27986398.
      Citations: 2     Fields:    Translation:Humans
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26076089.
      Citations: 6     
    19. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27130794.
      Citations: 14     Fields:    Translation:Humans
    20. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25415160.
      Citations: 14     Fields:    Translation:Humans
    21. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24674269.
      Citations: 9     Fields:    
    22. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25620163.
      Citations: 1     Fields:    Translation:Humans
    23. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25870376.
      Citations: 88     Fields:    Translation:Humans
    24. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26433678.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    25. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26553763.
      Citations: 15     Fields:    Translation:Humans
    26. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31655653.
      Citations:    Fields:    
    27. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30279048.
      Citations: 1     Fields:    Translation:Humans
    28. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30017792.
      Citations: 7     Fields:    Translation:HumansCells
    29. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30992185.
      Citations: 4     Fields:    Translation:Humans
    30. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31786169.
      Citations:    Fields:    Translation:Humans
    31. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32265119.
      Citations:    Fields:    Translation:Humans
    32. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32338316.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    33. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12445255.
      Citations:    Fields:    Translation:Humans
    34. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11121642.
      Citations: 13     Fields:    Translation:Humans
    35. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18267056.
      Citations: 5     Fields:    Translation:Humans
    36. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21035958.
      Citations:    Fields:    Translation:Humans
    37. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7635768.
      Citations: 52     Fields:    Translation:HumansPHPublic Health
    38. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3391810.
      Citations: 2     Fields:    Translation:Animals
    39. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21093170.
      Citations: 15     Fields:    Translation:Humans
    40. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10475822.
      Citations: 1     Fields:    Translation:Humans
    41. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8112646.
      Citations:    Fields:    Translation:Humans
    42. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15850914.
      Citations: 31     Fields:    Translation:Humans
    43. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15907987.
      Citations:    Fields:    Translation:Humans
    44. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 1917596.
      Citations: 1     Fields:    Translation:Humans
    45. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9023834.
      Citations: 1     Fields:    Translation:Humans
    46. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20171505.
      Citations: 96     Fields:    Translation:HumansPHPublic Health
    47. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2211212.
      Citations: 4     Fields:    Translation:Animals
    48. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2476427.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    49. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3583855.
      Citations: 6     Fields:    Translation:Humans
    50. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2337867.
      Citations: 23     Fields:    Translation:Humans
    51. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 1620041.
      Citations: 1     Fields:    Translation:Humans
    52. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 6236186.
      Citations:    Fields:    Translation:Animals
    53. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 6629891.
      Citations:    Fields:    Translation:AnimalsCells
    54. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7982597.
      Citations:    Fields:    Translation:Humans
    55. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10030261.
      Citations: 11     Fields:    Translation:Humans
    56. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9740698.
      Citations: 9     Fields:    Translation:Humans
    57. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14967435.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    58. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12182974.
      Citations:    Fields:    Translation:Humans
    59. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14675663.
      Citations: 57     Fields:    Translation:Humans
    60. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15882178.
      Citations: 3     Fields:    Translation:Humans
    61. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16099599.
      Citations: 17     Fields:    Translation:Humans
    62. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18513882.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    63. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17919835.
      Citations: 1     Fields:    Translation:HumansCells
    64. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19001332.
      Citations: 223     Fields:    Translation:Humans
    65. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19581056.
      Citations: 24     Fields:    Translation:Humans
    66. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19632709.
      Citations: 30     Fields:    Translation:Humans
    67. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18406887.
      Citations: 13     Fields:    Translation:HumansCells
    68. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20095264.
      Citations: 1     Fields:    Translation:Humans
    69. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24586086.
      Citations: 21     Fields:    Translation:Humans
    70. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8375732.
      Citations: 2     Fields:    Translation:Humans
    71. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8174061.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    72. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8270431.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    73. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7729748.
      Citations: 3     Fields:    Translation:Humans
    74. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8888818.
      Citations: 9     Fields:    Translation:Humans
    75. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7959262.
      Citations: 11     Fields:    Translation:Humans
    76. Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557. PMID: 27645621.
      Citations: 6     Fields:    Translation:Humans
    77. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):e165-e173. PMID: 27743802.
      Citations: 2     Fields:    Translation:Humans
    78. Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):793-800. PMID: 27788952.
      Citations: 4     Fields:    Translation:Humans
    79. Eifel PJ. Guidelines for endometrial cancer management: finding order amid the uncertainties. Ann Oncol. 2016 Feb; 27(2):212-3. PMID: 26658892.
      Citations:    Fields:    Translation:Humans
    80. Callegaro-Filho D, Gershenson DM, Nick AM, Munsell MF, Ramirez PT, Eifel PJ, Euscher ED, Marques RM, Nicolau SM, Schmeler KM. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases. Gynecol Oncol. 2016 Jan; 140(1):53-7. PMID: 26546963.
      Citations: 15     Fields:    Translation:Humans
    81. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynaecol Obstet. 2015 Oct; 131 Suppl 2:S84-7. PMID: 26433679.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    82. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol. 2015 Oct; 139(1):40-6. PMID: 26193429.
      Citations: 7     Fields:    Translation:Humans
    83. Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):260-7. PMID: 25968823.
      Citations: 9     Fields:    Translation:Humans
    84. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy. Int J Gynecol Cancer. 2015 Jun; 25(5):869-74. PMID: 25790043.
      Citations: 3     Fields:    Translation:Humans
    85. Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM. High-Grade Cervical Dysplasia following Radiation Therapy for Invasive Cervical Cancer: A Report of Four Cases. Case Rep Oncol. 2015 May-Aug; 8(2):217-21. PMID: 26078740.
      Citations: 1     
    86. Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE. Brachytherapy: where has it gone? J Clin Oncol. 2015 Mar 20; 33(9):980-2. PMID: 25667278.
      Citations: 17     Fields:    Translation:Humans
    87. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73. PMID: 25524458.
      Citations: 5     Fields:    Translation:Humans
    88. Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53. PMID: 25451695.
      Citations: 33     Fields:    Translation:Humans
    89. Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 01; 91(1):196-205. PMID: 25446609.
      Citations: 14     Fields:    Translation:Humans
    90. Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Management of advanced primary urethral carcinomas. BJU Int. 2014 Jul; 114(1):25-31. PMID: 24447439.
      Citations: 25     Fields:    Translation:Humans
    91. Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ. A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):65-70. PMID: 24890345.
      Citations: 7     Fields:    Translation:Humans
    92. Smith GL, Eifel PJ. Trends in the utilization of brachytherapy in cervical cancer in the United States. In regard to Han et al. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):459-60. PMID: 24411614.
      Citations: 7     Fields:    Translation:Humans
    93. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):357-62. PMID: 24411609.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    94. Eifel PJ, Ho A, Khalid N, Erickson B, Owen J. Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):249-56. PMID: 24411621.
      Citations: 15     Fields:    Translation:Humans
    95. Tanderup K, Eifel PJ, Yashar CM, Pötter R, Grigsby PW. Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):537-9. PMID: 24411631.
      Citations: 40     Fields:    Translation:Humans
    96. Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy. 2014 May-Jun; 13(3):240-9. PMID: 24188993.
      Citations: 1     Fields:    Translation:Humans
    97. Eifel PJ. The value of pelvic radiation therapy after hysterectomy for early endometrial cancer. Oncology (Williston Park). 2013 Oct; 27(10):990-9. PMID: 24367856.
      Citations: 1     Fields:    Translation:Humans
    98. Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil. Int J Gynecol Cancer. 2013 Oct; 23(8):1520-7. PMID: 24257567.
      Citations:    Fields:    Translation:Humans
    99. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):300-5. PMID: 23648467.
      Citations: 18     Fields:    Translation:Humans
    100. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol. 2013 Dec; 131(3):645-9. PMID: 23643871.
      Citations: 13     Fields:    Translation:Humans
    101. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Giuntoli RL, Han E, Huh WK, Lurain JR, Martin L, Morgan MA, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Tillmanns T, Valea FA, McMillian NR, Hughes M. Cervical cancer. J Natl Compr Canc Netw. 2013 Mar 01; 11(3):320-43. PMID: 23486458.
      Citations: 38     Fields:    Translation:Humans
    102. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9. PMID: 23385150.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    103. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50. PMID: 23332221.
      Citations: 8     Fields:    Translation:Humans
    104. Eifel PJ. The role of adjuvant radiation therapy for stage I endometrial cancer: does meta-analysis reveal the answer? J Natl Cancer Inst. 2012 Nov 07; 104(21):1615-6. PMID: 23104209.
      Citations:    Fields:    Translation:Humans
    105. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynaecol Obstet. 2012 Oct; 119 Suppl 2:S97-9. PMID: 22999510.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    106. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet. 2012 Oct; 119 Suppl 2:S90-6. PMID: 22999509.
      Citations: 12     Fields:    Translation:Humans
    107. Frumovitz M, Jhingran A, Soliman P, Klopp A, Ramirez P, Eifel P. Morbid obesity is an independent risk factor in cervical cancer survival. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S7. PMID: 24989592.
      Citations:    
    108. Eifel PJ. Regional treatment of vulvar cancer; lessons from the past and lessons for the future. Pract Radiat Oncol. 2012 Oct-Dec; 2(4):279-281. PMID: 24674165.
      Citations: 1     Fields:    
    109. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):115-23. PMID: 24674314.
      Citations: 2     Fields:    
    110. Costales AB, Eifel PJ, Deavers MT, Frumovitz M, Schmeler KM. Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix. Gynecol Oncol Case Rep. 2012; 2(3):97-9. PMID: 24371632.
      Citations: 1     
    111. Gaffney D, Mundt A, Schwarz J, Eifel P. Advances in clinical research in gynecologic radiation oncology: an RTOG symposium. Int J Gynecol Cancer. 2012 May; 22(4):667-74. PMID: 22398709.
      Citations: 3     Fields:    Translation:Humans
    112. Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol. 2012 Apr; 22(2):143-50. PMID: 22385921.
      Citations: 11     Fields:    Translation:Humans
    113. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):45-53. PMID: 24674263.
      Citations: 3     Fields:    
    114. Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e417-22. PMID: 22436788.
      Citations: 10     Fields:    Translation:Humans
    115. Small W, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012 Jan-Feb; 11(1):58-67. PMID: 22265439.
      Citations: 55     Fields:    Translation:Humans
    116. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):53-7. PMID: 22265438.
      Citations: 16     Fields:    Translation:Humans
    117. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):2012-7. PMID: 21640510.
      Citations: 1     Fields:    Translation:Humans
    118. Fisher CM, Fortenberry BR, Jhingran A, Eifel PJ. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol. 2011 Jul-Sep; 1(3):152-5. PMID: 24673944.
      Citations: 4     Fields:    
    119. Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep. 2011 Feb; 13(1):77-85. PMID: 21042887.
      Citations: 5     Fields:    Translation:Humans
    120. Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA. Cervical cancer. J Natl Compr Canc Netw. 2010 Dec; 8(12):1388-416. PMID: 21147903.
      Citations: 26     Fields:    Translation:Humans
    121. Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365. PMID: 21099603.
      Citations: 25     Fields:    Translation:Humans
    122. Eifel PJ. Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment. Nat Rev Clin Oncol. 2010 Oct; 7(10):553-4. PMID: 20877416.
      Citations: 3     Fields:    Translation:Humans
    123. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1331-6. PMID: 20231067.
      Citations: 3     Fields:    Translation:Humans
    124. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30. PMID: 20052724.
      Citations: 35     Fields:    Translation:HumansPHPublic Health
    125. Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat. J Appl Clin Med Phys. 2010 Jan 28; 11(1):3146. PMID: 20160700.
      Citations: 1     Fields:    Translation:Humans
    126. Gifford KA, Wareing TA, Failla G, Horton JL, Eifel PJ, Mourtada F. Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri. J Appl Clin Med Phys. 2009 Dec 03; 11(1):3103. PMID: 20160682.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    127. Price MJ, Gifford KA, Horton JL, Eifel PJ, Gillin MT, Lawyer AA, Mourtada F. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer. Med Phys. 2009 Sep; 36(9):4147-55. PMID: 19810488.
      Citations: 2     Fields:    Translation:Humans
    128. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12. PMID: 19820377.
      Citations: 2     Fields:    Translation:Humans
    129. Holmes T, Das R, Low D, Yin FF, Balter J, Palta J, Eifel P. American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys. 2009 Aug 01; 74(5):1311-8. PMID: 19616738.
      Citations: 10     Fields:    Translation:Humans
    130. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W, Teng N. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2009 May; 7(5):498-531. PMID: 19460278.
      Citations: 11     Fields:    Translation:Humans
    131. Eifel PJ. Studies of adjuvant treatment for endometrial cancer. Oncology (Williston Park). 2009 Apr 15; 23(4):364-5. PMID: 19476266.
      Citations:    Fields:    Translation:Humans
    132. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer. 2009 Jan; 19(1):2-7. PMID: 19258933.
      Citations: 9     Fields:    Translation:Humans
    133. Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM. Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):323-6. PMID: 18793951.
      Citations:    Fields:    
    134. McGuire SE, Frank SJ, Eifel PJ. Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):359-63. PMID: 18778972.
      Citations: 2     Fields:    Translation:Humans
    135. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25. PMID: 17869451.
      Citations: 11     Fields:    Translation:Humans
    136. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W, Greven K. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):111-7. PMID: 17482376.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    137. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol. 2007 May; 105(2):470-4. PMID: 17292459.
      Citations: 10     Fields:    Translation:Humans
    138. Mourtada F, Gifford KA, Berner PA, Horton JL, Price MJ, Lawyer AA, Eifel PJ. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids. Med Dosim. 2007; 32(3):181-7. PMID: 17707197.
      Citations: 1     Fields:    Translation:Humans
    139. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):104-9. PMID: 17084549.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    140. Price MJ, Gifford KA, Horton J, Lawyer A, Eifel P, Mourtada F. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study. Phys Med Biol. 2006 Aug 21; 51(16):4083-94. PMID: 16885626.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    141. Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol. 2006 Dec; 103(3):948-51. PMID: 16870239.
      Citations: 8     Fields:    Translation:Humans
    142. Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol. 2006 Jul; 16(3):177-85. PMID: 16814159.
      Citations: 19     Fields:    Translation:Humans
    143. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N. Uterine cancers. J Natl Compr Canc Netw. 2006 May; 4(5):438-62. PMID: 16687093.
      Citations: 3     Fields:    Translation:Humans
    144. Klopp AH, Eifel PJ. Gene expression profiling in cervical cancer: state of the art and future directions. Cancer J. 2006 May-Jun; 12(3):170-4. PMID: 16803672.
      Citations: 1     Fields:    Translation:Humans
    145. Eifel PJ. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer. Nat Clin Pract Oncol. 2006 May; 3(5):248-55. PMID: 16683003.
      Citations: 17     Fields:    Translation:Humans
    146. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1106-11. PMID: 16803493.
      Citations: 4     Fields:    Translation:Humans
    147. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36. PMID: 16234510.
      Citations: 104     Fields:    Translation:Humans
    148. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study. Phys Med Biol. 2005 Nov 07; 50(21):5075-87. PMID: 16237242.
      Citations: 2     Fields:    Translation:Humans
    149. Eifel PJ. Chemoradiotherapy for cervical cancer: what next? J Clin Oncol. 2005 Nov 20; 23(33):8277-9. PMID: 16230671.
      Citations:    Fields:    Translation:Humans
    150. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005 Oct 01; 63(2):615-21. PMID: 16168853.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    151. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys. 2005 Jul 15; 62(4):1117-24. PMID: 15990017.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    152. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):131-7. PMID: 15850913.
      Citations: 32     Fields:    Translation:Humans
    153. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1062-70. PMID: 15752885.
      Citations: 9     Fields:    Translation:Humans
    154. Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1144-53. PMID: 15519786.
      Citations: 27     Fields:    Translation:Humans
    155. Teng N, Abu-Rustum NR, Bahador A, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Fiorica J, Greer BE, Kapp DS, Kavanagh J, Koh WJ, Kuettel M, Lurain JR, Molpus KL, Nag S, Partridge EE, Powell CB, Reynolds RK, Small W, Soper J, Tillmanns TD. Cervical cancer guidelines. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2004 Nov; 2(6):612-30. PMID: 19780304.
      Citations: 2     Fields:    Translation:Humans
    156. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004 Aug; 94(2):456-62. PMID: 15297188.
      Citations: 46     Fields:    Translation:Humans
    157. Eifel PJ. Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer? Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):637-8. PMID: 15183466.
      Citations:    Fields:    Translation:Humans
    158. van der Velden J, Ansink A. In regards to Katz et al.: The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva (Int J Radiat Oncol Biol Phys 2003;57:409-418). Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1635; author reply 1635-6. PMID: 15050345.
      Citations:    Fields:    Translation:HumansPHPublic Health
    159. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33. PMID: 15047210.
      Citations: 47     Fields:    Translation:Humans
    160. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004 Mar 01; 22(5):872-80. PMID: 14990643.
      Citations: 238     Fields:    Translation:HumansCTClinical Trials
    161. Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10. PMID: 14751159.
      Citations: 4     Fields:    Translation:Humans
    162. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2052-63. PMID: 14603542.
      Citations: 4     Fields:    Translation:Humans
    163. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):409-18. PMID: 12957252.
      Citations: 15     Fields:    Translation:Humans
    164. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1366-72. PMID: 12873682.
      Citations: 22     Fields:    Translation:Humans
    165. Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol. 2003 Jun; 180(6):1621-31. PMID: 12760933.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    166. Pothuri B, Ramondetta L, Martino M, Alektiar K, Eifel PJ, Deavers MT, Venkatraman E, Soslow RA, Barakat RR. Development of endometrial cancer after radiation treatment for cervical carcinoma. Obstet Gynecol. 2003 May; 101(5 Pt 1):941-5. PMID: 12738155.
      Citations: 3     Fields:    Translation:Humans
    167. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002 Sep 01; 20(17):3651-7. PMID: 12202666.
      Citations: 39     Fields:    Translation:HumansPHPublic Health
    168. Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001 Nov 15; 51(4):982-7. PMID: 11704321.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    169. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001 Jul 04; 93(13):979-89. PMID: 11438563.
      Citations: 145     Fields:    Translation:Humans
    170. Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DM. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5. PMID: 11426977.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    171. Rose PG, Eifel PJ. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Cancer J. 2001 Mar-Apr; 7(2):86-94. PMID: 11324770.
      Citations: 2     Fields:    Translation:HumansAnimals
    172. Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):58-9. PMID: 11641017.
      Citations:    Fields:    Translation:Humans
    173. Eifel PJ. Chemoradiation for carcinoma of the cervix: advances and opportunities. Radiat Res. 2000 Sep; 154(3):229-36. PMID: 11012341.
      Citations: 2     Fields:    Translation:Humans
    174. Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000 Aug; 78(2):187-93. PMID: 10926801.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    175. Katz A, Eifel PJ, Moughan J, Owen JB, Mahon I, Hanks GE. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int J Radiat Oncol Biol Phys. 2000 May 01; 47(2):443-50. PMID: 10802372.
      Citations: 5     Fields:    Translation:Humans
    176. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000 Mar 15; 46(5):1177-83. PMID: 10725629.
      Citations: 8     Fields:    Translation:Humans
    177. Chaney AW, Eifel PJ, Logsdon MD, Morris M, Wharton JT. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):113-8. PMID: 10477014.
      Citations:    Fields:    Translation:HumansPHPublic Health
    178. Logsdon MD, Eifel PJ. Low dose rate brachytherapy in the treatment of cervical carcinoma. Hematol Oncol Clin North Am. 1999 Jun; 13(3):577-84. PMID: 10432430.
      Citations: 1     Fields:    Translation:Humans
    179. Eifel PJ. Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. J Clin Oncol. 1999 May; 17(5):1334-5. PMID: 10334515.
      Citations: 2     Fields:    Translation:Humans
    180. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15; 340(15):1137-43. PMID: 10202164.
      Citations: 401     Fields:    Translation:HumansCTClinical Trials
    181. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41. PMID: 10094877.
      Citations: 13     Fields:    Translation:Humans
    182. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999 Mar 01; 43(4):763-75. PMID: 10098431.
      Citations: 49     Fields:    Translation:Humans
    183. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys. 1998 Jul 01; 41(4):817-22. PMID: 9652843.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    184. Morris M, Eifel PJ. An interesting observation in a retrospective review of 171 women treated for cervical cancer with radical hysterectomy. Gynecol Oncol. 1997 Dec; 67(3):328-9. PMID: 9441784.
      Citations:    Fields:    Translation:Humans
    185. Eifel PJ. Intracavitary brachytherapy in the treatment of gynecologic neoplasms. J Surg Oncol. 1997 Oct; 66(2):141-7. PMID: 9354174.
      Citations: 5     Fields:    Translation:Humans
    186. National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996. Gynecol Oncol. 1997 Sep; 66(3):351-61. PMID: 9312522.
      Citations: 10     Fields:    Translation:Humans
    187. Eifel PJ. The importance of locoregional control of cervical cancer--why is it still controversial? Cancer J Sci Am. 1996 Sep-Oct; 2(5):253-5. PMID: 9166541.
      Citations: 1     Fields:    Translation:Humans
    188. Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996 Jun; 34(6):1022-9. PMID: 8647968.
      Citations: 10     Fields:    Translation:Humans
    189. Wagner LK, Eifel P, Geise R. Effects of ionizing radiation. J Vasc Interv Radiol. 1995 Nov-Dec; 6(6):988-9. PMID: 8850686.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    190. Ripley D, Levenback C, Eifel P, Lewis RM. Adenocarcinoma of the cervix in a renal transplant patient. Gynecol Oncol. 1995 Oct; 59(1):151-5. PMID: 7557603.
      Citations: 3     Fields:    Translation:Humans
    191. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6. PMID: 7557615.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    192. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44. PMID: 7557613.
      Citations: 48     Fields:    Translation:Humans
    193. Eifel PJ, Thames HD. Has the influence of treatment duration on local control of carcinoma of the cervix been defined? Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1527-9. PMID: 7635797.
      Citations: 4     Fields:    Translation:Humans
    194. Wheeler JA, Stephens LC, Tornos C, Eifel PJ, Ang KK, Milas L, Allen PK, Meyn RE. ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1487-93. PMID: 7635794.
      Citations: 17     Fields:    Translation:Humans
    195. Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8. PMID: 7705704.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    196. Eifel PJ, Donaldson SS, Thomas PR. Response of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys. 1995 Mar 30; 31(5):1301-7. PMID: 7713789.
      Citations: 10     Fields:    Translation:Humans
    197. Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, Stetz J, Stitt JA, Sullivan J. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys. 1995 Mar 30; 31(5):1281-99. PMID: 7713788.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    198. Eifel PJ, Morris M. Irradiation alone or combined with surgery in carcinoma of the cervix: when will we know the answer? Int J Radiat Oncol Biol Phys. 1995 Feb 15; 31(4):1007-8. PMID: 7860371.
      Citations:    Fields:    Translation:Humans
    199. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995 Feb 01; 75(3):836-43. PMID: 7828135.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    200. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10. PMID: 7959285.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    201. Auger M, Raney B, Callender D, Eifel P, Ordóñez NG. Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Pediatr Pathol. 1994 Sep-Oct; 14(5):763-70. PMID: 7808974.
      Citations: 8     Fields:    Translation:HumansCells
    202. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994 Apr 30; 29(1):9-16. PMID: 8175451.
      Citations: 41     Fields:    Translation:Humans
    203. Levenback C, Gershenson DM, McGehee R, Eifel PJ, Morris M, Burke TW. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300. PMID: 8157186.
      Citations: 3     Fields:    Translation:Humans
    204. Eifel PJ. Vulvar carcinoma: radiotherapy or surgery for the lymphatics? Front Radiat Ther Oncol. 1994; 28:218-25. PMID: 7982599.
      Citations:    Fields:    Translation:Humans
    205. Wagner LK, Eifel PJ, Geise RA. Potential biological effects following high X-ray dose interventional procedures. J Vasc Interv Radiol. 1994 Jan-Feb; 5(1):71-84. PMID: 8136601.
      Citations: 67     Fields:    Translation:Humans
    206. Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ. Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1993 Nov 15; 27(4):817-24. PMID: 8244810.
      Citations: 5     Fields:    Translation:Humans
    207. Eifel PJ. Does tumor hypoxia influence local control of carcinoma of the cervix? Gynecol Oncol. 1993 Nov; 51(2):139-40. PMID: 8305082.
      Citations:    Fields:    Translation:Humans
    208. Patton TJ, Follen Mitchell M, Neely Atkinson E, Eifel P, Gastorf L, Yancey C, Miller D, Wharton JT. Parameters of small bowel dysfunction in cervical cancer patients undergoing radiotherapy. Int J Gynecol Cancer. 1993 May; 3(3):175-182. PMID: 11578340.
      Citations:    Fields:    
    209. Matthews CM, Burke TW, Tornos C, Eifel PJ, Atkinson EN, Stringer CA, Morris M, Silva EG. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23. PMID: 8482554.
      Citations: 4     Fields:    Translation:Humans
    210. Eifel PJ. Radiotherapy versus radical surgery for gynecologic neoplasms: carcinomas of the cervix and vulva. Front Radiat Ther Oncol. 1993; 27:130-42. PMID: 8504941.
      Citations: 2     Fields:    Translation:Humans
    211. Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, Wharton JT. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992 Oct; 47(1):62-5. PMID: 1330847.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    212. Roman LD, Morris M, Eifel PJ, Burke TW, Gershenson DM, Wharton JT. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9. PMID: 1553163.
      Citations:    Fields:    Translation:Humans
    213. Eifel PJ. High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk? Int J Radiat Oncol Biol Phys. 1992; 24(2):383-6; discussion 387-8. PMID: 1526879.
      Citations: 7     Fields:    Translation:Humans
    214. Kavadi VS, Eifel PJ. FIGO stage IIIA carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1992; 24(2):211-5. PMID: 1526857.
      Citations: 3     Fields:    Translation:Humans
    215. Thoms WW, Eifel PJ, Smith TL, Morris M, Delclos L, Wharton JT, Oswald MJ. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 1992; 23(3):491-9. PMID: 1612949.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    216. Eifel PJ, Burke TW, Delclos L, Wharton JT, Oswald MJ. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205. PMID: 1869095.
      Citations: 8     Fields:    Translation:Humans
    217. Belli JA, Eifel PJ, Menache L, Kennamer D. Twice-daily anesthesia in children. Int J Radiat Oncol Biol Phys. 1991 Apr; 20(4):909-10. PMID: 2004975.
      Citations: 1     Fields:    Translation:Humans
    218. Mitchell MF, Gershenson DM, Soeters RP, Eifel PJ, Delclos L, Wharton JT. The long-term effects of radiation therapy on patients with ovarian dysgerminoma. Cancer. 1991 Feb 15; 67(4):1084-90. PMID: 1991256.
      Citations:    Fields:    Translation:HumansPHPublic Health
    219. Eifel PJ, Hendrickson M. Stage I endometrial carcinoma: the importance of pathologic review in retrospective analyses. Int J Radiat Oncol Biol Phys. 1990 May; 18(5):1271-3. PMID: 2347735.
      Citations:    Fields:    Translation:Humans
    220. Menache L, Eifel PJ, Kennamer DL, Belli JA. Twice-daily anesthesia in infants receiving hyperfractionated irradiation. Int J Radiat Oncol Biol Phys. 1990 Mar; 18(3):625-9. PMID: 2318696.
      Citations: 3     Fields:    Translation:Humans
    221. Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol. 1983 Dec; 7(8):715-29. PMID: 6318581.
      Citations: 5     Fields:    Translation:Humans
    222. Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons. Cancer. 1983 Sep 15; 52(6):1026-31. PMID: 6883271.
      Citations: 5     Fields:    Translation:Humans
    223. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer. 1982 Jul 01; 50(1):163-70. PMID: 7083121.
      Citations: 22     Fields:    Translation:Humans
    224. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol. 1982 Jun; 13(3):373-92. PMID: 6284595.
      Citations: 11     Fields:    Translation:Humans
    225. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982 Mar; 6(2):93-108. PMID: 7102898.
      Citations: 89     Fields:    Translation:Humans
    226. Brown SB, Brant-Zawadzki M, Eifel P, Coleman CN, Enzmann DR. CT of irradiated solid tumor metastases to the brain. Neuroradiology. 1982; 23(3):127-31. PMID: 7088282.
      Citations: 1     Fields:    Translation:Humans
    227. Eifel P, Billingsley A, Lucas ZJ. Rapid killing of viral-infected L cells by alpha-lymphotoxin. Cell Immunol. 1979 Sep 15; 47(1):197-203. PMID: 228866.
      Citations:    Fields:    Translation:HumansAnimalsCells
    228. Eifel PJ, Walker SM, Lucas ZJ. Standardization of a sensitive and rapid assay for lymphotoxin. Cell Immunol. 1975 Jan; 15(1):208-21. PMID: 45839.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    229. Effects of music relaxation video on pain and anxiety for women with gynaecological cancer receiving intracavitary brachytherapy. Journal of Research in Nursing. 20:129-144.
    230. Evolution of radiotherapy in pediatric oncology. Cancer Bulletin. 44:457-460.
    231. Erratum. International Journal of Gynecology and Obstetrics. 132:365.
    232. Over 20 years of progress in radiation oncology. Seminars in Radiation Oncology. 7:121-126.
    233. Cervical cancer. 97-107.
    234. In response to Dr. Beitler [3]. International Journal of Radiation Oncology Biology Physics. 50:837-838.
    235. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. ACOG Current Journal Review. 8:32.
    236. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Practical Radiation Oncology.
    237. The value of pelvic radiation therapy after hysterectomy for early endometrial cancer. ONCOLOGY (United States). 27.
    238. Intensity-modulated radiation therapy for carcinomas of the uterine cervix and endometrium. 411-422.
    239. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Practical Radiation Oncology. 3.
    240. Parameters of small bowel dysfunction in cervical cancer patients undergoing radiotherapy. International Journal of Gynecological Cancer. 3:175-182.
    241. Regional treatment of vulvar cancer; lessons from the past and lessons for the future. Practical Radiation Oncology. 2:279-281.
    242. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Practical Radiation Oncology. 3:115-123.
    243. Vaginal cancer. 608-624.
    244. Radiation therapy. 85-122.
    245. Role of radiation therapy. Best Practice and Research: Clinical Obstetrics and Gynaecology.
    246. Radiotherapy for recurrent small cell carcinoma of the ovary. Gynecologic Oncology Case Reports. 11:23-25.
    247. Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer. International Journal of Gynecological Cancer. 25:869-874.
    248. Vulvar cancer, version 1.2017. JNCCN Journal of the National Comprehensive Cancer Network. 15:92-120.
    249. Comparison of a 3D multi-group SN particle transport code with Monte Carlo for intercavitary brachytherapy of the cervix uteri. Journal of Applied Clinical Medical Physics. 11:2-9.
    250. Cancer of the cervix, vagina, and vulva.
    251. Erratum. Journal of the American Academy of Dermatology. 35:587.
    252. A multidisciplinary approach to cancer. 17-24.
    253. International Journal of Radiation Oncology Biology Physics. 96:793-800.
    254. Node-positive adenocarcinoma of the endometrium. Obstetrical and Gynecological Survey. 64:798-800.
    255. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Practical Radiation Oncology. 3:45-53.
    256. Ovarian cancer. 455-478.
    257. Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14years following hysterectomy for adenocarcinoma in situ of the cervix. Gynecologic Oncology Case Reports. 2:97-99.
    258. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus. Obstetrical and Gynecological Survey. 39:124.
    259. An extensive Ewing's sarcoma of the left ischium treatment by optimal systemic chemotherapy, intra-arterial dactinomycin, and delayed irradiation. International Journal of Pediatric Hematology/Oncology. 4:137-142.
    260. Schiff base formation of the reduction product of misonidazole and pyridoxal as a possible mechanism for misonidazole neurotoxicity. Radiation Research. 91:394-395.
    261. Vulvar cancer. 560-607.
    262. Treatment of endometrial cancer. 315-325.
    263. Pelvic irradiation with concurrent chemotherapy versus pelvic for high-risk cervical cancer. Women's Oncology Review. 4:127-128.
    264. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. International Journal of Radiation Oncology Biology Physics.
    265. Novel technique for simulation and external beam treatment planning for obese patients. Practical Radiation Oncology. 1:152-155.
    266. Early-Stage Cervical Cancer. 161-174.
    267. Problems with the clinical staging of carcinoma of the cervix. Seminars in Radiation Oncology. 4:1-8.
    268. Irradiation of pelvic and para-aortic nodes in carcinoma of the cervix. Seminars in Radiation Oncology. 4:23-29.
    269. Imaging in oncology from The University of Texas M. D. Anderson Cancer Center. American Journal of Roentgenology. 180:1621-1632.
    270. High-grade cervical dysplasia following radiation therapy for invasive cervical cancer. Case Reports in Oncology. 8:217-221.
    271. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecologic Oncology. 143:552-557.
    EIFEL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (449)
    Explore
    _
    Co-Authors (68)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _